This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Organizing Committee

Anil_Lalwani_IFOS.jpg

Anil Lalwani

Professor and Vice Chairman
Columbia University College of Physician & Surgeons
United States

ANIL K. LALWANI, MD is Professor and Vice Chair for Research, Director of Division of Otology, Neurotology & Skull Base Surgery, and Co-Director of Columbia Cochlear Implant Program in the Department of Otolaryngology at Columbia University College of Physicians and Surgeons. In addition, he serves as the Medical Director of Perioperative Services at New York Presbyterian — Columbia University Medical Center. He has served as the President of American Neurotology Society (2014-2015) and President of the American Auditory Society (2017-2018). He previously served as Chairman, Department of Otolaryngology-Head & Neck Surgery at New York University School of Medicine.

Dr. Lalwani earned his M.D. from the University of Michigan Medical School in 1985 and subsequently completed is internship in General and Thoracic Surgery at Duke University Medical Center and his residency in Otolaryngology-Head and Neck Surgery at University of California San Francisco (UCSF). Following subspecialty training in Neurotology and Skull base surgery, he served as Senior staff Fellow at the National Institute on Deafness and Other Communication Disorders, National Institute of Health. In 1994, he joined the faculty at UCSF as an assistant professor and rose to the rank of Professor in 2002. In April 2003, Dr. Lalwani was recruited to New York University School of Medicine to serve as Mendik Foundation Professor and Chairman of the Department of Otolaryngology — a position he held until December 2009.

Doctor Lalwani’s basic research has focused on two key areas: identifying genes that are critical for hearing through the use of molecular genetic and molecular biologic methods, and developing and investigating gene transfer technology for the treatment of hearing disorders. More recently, his NIH funded research has focused on the development of microneedle technology for inner ear delivery. His clinical interests are in otology include cochlear implantation, chronic ear disease, facial nerve disorders, Meniere’s disease, cerebellopontine angle tumors (e.g. acoustic neuromas), and skull base surgery.

Dr. Lalwani is considered one of the leading experts on hearing loss in children and adults. He is the author of more than 200 peer-reviewed articles, and numerous book chapters. He serves on the editorial board of numerous leading otolaryngology journals; he is the Section Editor of Triological Society Best Practice – a popular feature published in Laryngoscope. He has published numerous books including the textbook defining the subspecialty of Pediatric Otology and Neurotology. The 4th edition of his highly successful second book, CURRENT DIAGNOSIS & TREATMENT IN OTOLARYNGOLOGY-HEAD & NECK SURGERY has been translated into Spanish, Turkish, and Portuguese. The 6th edition of RECENT ADVANCES IN OTOLARYNGOLOGY-HEAD AND NECK SURGERY was published in January 2017. Most recently, Dr. Lalwani’s OTOLOGY, NEUROTOLOGY, AND SKULL BASE SURGERY volume of Sataloff’s Comprehensive Textbook of Otolaryngology Head & Neck Surgery was published.